Analysis of epigenetic and neuronal circuit changes in autism on the single-cell level
单细胞水平分析自闭症的表观遗传和神经元回路变化
基本信息
- 批准号:10696952
- 负责人:
- 金额:$ 24.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-02 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:ASD patientATAC-seqAffectAllelesAreaAutopsyAwardBar CodesBrainCandidate Disease GeneCell NucleusCellsChildChromatinChromatin Remodeling FactorCre lox recombination systemDNA-Binding ProteinsDataData SetDevelopmentEngineeringEnterobacteria phage P1 Cre recombinaseEpigenetic ProcessExhibitsGene ExpressionGene Expression ProfileGenerationsGenesGenetic EngineeringGenetic HeterogeneityGenetic TranscriptionGenomeGenomic approachGenomicsGoalsHeterogeneityHumanJointsLabelLeadLibrariesMapsModelingMolecularMusMutateNeocortexNeurodevelopmental DisorderNeurogliaNeuronsOligonucleotidesPathogenesisPathway interactionsPatientsPhasePhenotypePoly APolyadenylationPostdoctoral FellowProcessProtocols documentationPublishingRNARabiesRabies virusRecurrenceRegulatory ElementReporterResearchResearch PersonnelResearch Project GrantsRiskRisk FactorsSignal TransductionSynapsesSynaptic TransmissionSystemSystems BiologyTechniquesTestingTissuesTrainingUnited StatesViralVirionVirusWild Type MouseWorkXCL1 geneautism spectrum disorderautisticbrain tissuecell cortexcell typeclinical heterogeneitycohortcomparison controleffective therapyepigenetic profilingepigenetic regulationgenetic risk factorglobal healthhelicasein vivoinsightloss of functionloss of function mutationmolecular pathologymouse modelneocorticalneural circuitneuronal circuitrynovelprecision medicinesequencing platformsingle nucleus RNA-sequencingsingle-cell RNA sequencingskillstargeted treatmenttooltranscriptome sequencingtranscriptomicsvectorviral RNA
项目摘要
Project Summary/Abstract
Autism Spectrum Disorder (ASD) is a neurodevelopmental disease affecting almost 2% of children in the US
alone. Despite its genetic and clinical heterogeneity, recent systems biology and genomics studies demonstrated
that ASD converges on a specific set of cellular pathways. Epigenetic regulation and synaptic signaling emerged
as the two most prominent pathways in ASD, with many high-confidence genetic risk factors and dysregulated
genes involved in these processes. This observation prompted a hypothesis that epigenetic dysregulation leads
to improper neuronal circuit development and function, which has been demonstrated in mouse models of
epigenetic regulators recurrently mutated in ASD, such as CHD8 (Chromodomain Helicase DNA Binding Protein
8). However, the exact epigenetic changes, cell types they affect and the neuronal circuitry changes resulting
from epigenetic dysregulation in ASD are unknown. Recently, single-cell genomics approaches, including single-
cell RNA sequencing and single-cell ATAC sequinning, offered unprecedented new level of detail of cellular and
molecular composition of the brain, as well as processes underlying its development. In my postdoc, I applied
single-nucleus RNA sequencing to human post-mortem cortical tissue from ASD patients to gain insight into the
molecular changes associated with ASD in specific neuronal and glial subtypes. One of the most important
insights from this work is the implication of upper-layer cortical neurons as the cell type most affected by ASD-
associated transcriptional changes. This observation raises questions about the origin and functional effects of
such changes on specific neuronal circuits. As part of the Aim 1 of my K99 proposal, I will test the hypothesis
that gene expression changes in ASD are driven by changes in epigenetic states of specific cell types. To that
end, I will perform a joint RNA-seq and ATAC-seq profiling of neocortical tissue of ASD patients and controls to
identify cell type-specific epigenetic changes. Then, I will develop and test a high-throughput synaptic tracing
technique by combining barcoded rabies virus library with single-nucleus RNA sequencing (Aim 2 of K99 phase).
Finally, using the training, tools and preliminary data from the K99 phase of my proposal, I will launch an
independent research project that focuses on investigating cell-type specific epigenetic and neuronal circuitry
changes in the Chd8+/ mouse model during development (R00 phase). I will first apply the joint RNA-seq/ATAC-
seq protocol to study epigenetic changes in specific cell types during development caused by the loss of one of
Chd8 alleles. By crossing the Chd8+/ mouse with reporter lines expressing Cre recombinase in specific neuronal
subtypes, such as upper-layer cortical neurons (Cux2-Cre), I will be able to use the barcoded rabies virus library
and single-nucleus RNA-seq to identify changes in specific components of cortical circuitry as the result of Chd8
haploinsufficiency. I believe that the K99-R00 award will allow me to form a unique research direction and
establish myself as a successful independent investigator in the area of autism and single-cell genomics.
项目概要/摘要
自闭症谱系障碍 (ASD) 是一种神经发育疾病,影响美国近 2% 的儿童
独自的。尽管存在遗传和临床异质性,但最近的系统生物学和基因组学研究表明
自闭症谱系障碍(ASD)集中在一组特定的细胞通路上。表观遗传调控和突触信号传导出现
作为自闭症谱系障碍 (ASD) 中两个最重要的途径,具有许多高置信度遗传风险因素和失调
参与这些过程的基因。这一观察结果提出了一个假设,即表观遗传失调会导致
神经元回路发育和功能不当,这已在小鼠模型中得到证实
表观遗传调节因子在 ASD 中反复突变,例如 CHD8(染色质解旋酶 DNA 结合蛋白)
8).然而,确切的表观遗传变化、它们影响的细胞类型以及导致的神经元回路变化
自闭症谱系障碍 (ASD) 中的表观遗传失调引起的影响尚不清楚。最近,单细胞基因组学方法,包括单细胞
细胞 RNA 测序和单细胞 ATAC 亮片加工,提供了前所未有的细胞和细胞细节的新水平
大脑的分子组成,以及其发育的过程。在我的博士后期间,我申请了
对 ASD 患者死后皮质组织进行单核 RNA 测序,以深入了解
特定神经元和神经胶质亚型中与 ASD 相关的分子变化。最重要的之一
这项工作的见解表明,上层皮质神经元是受自闭症谱系障碍 (ASD) 影响最严重的细胞类型。
相关的转录变化。这一观察结果提出了关于起源和功能效应的问题
特定神经元回路的这种变化。作为 K99 提案目标 1 的一部分,我将检验假设
ASD 中基因表达的变化是由特定细胞类型的表观遗传状态的变化驱动的。对此
最后,我将对 ASD 患者和对照的新皮质组织进行联合 RNA-seq 和 ATAC-seq 分析,以
识别细胞类型特异性的表观遗传变化。然后,我将开发并测试高通量突触追踪
通过将带有条形码的狂犬病病毒库与单核RNA测序相结合的技术(K99阶段的目标2)。
最后,利用我提案 K99 阶段的培训、工具和初步数据,我将启动一个
专注于研究细胞类型特异性表观遗传和神经元回路的独立研究项目
Chd8+/小鼠模型在开发过程中(R00阶段)的变化。我将首先应用联合RNA-seq/ATAC-
seq 协议,用于研究特定细胞类型在发育过程中由于其中一种缺失而引起的表观遗传变化
Chd8 等位基因。通过将 Chd8+/ 小鼠与在特定神经元中表达 Cre 重组酶的报告系杂交
亚型,例如上层皮质神经元 (Cux2-Cre),我将能够使用带条形码的狂犬病病毒库
和单核 RNA-seq 来识别 Chd8 导致的皮质电路特定成分的变化
单倍体不足。我相信K99-R00奖将使我形成独特的研究方向并
使自己成为自闭症和单细胞基因组学领域成功的独立研究者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dmitry Velmeshev其他文献
Dmitry Velmeshev的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dmitry Velmeshev', 18)}}的其他基金
Analysis of epigenetic and neuronal circuit changes in autism on the single-cell level
单细胞水平分析自闭症的表观遗传和神经元回路变化
- 批准号:
10611017 - 财政年份:2022
- 资助金额:
$ 24.75万 - 项目类别:
相似国自然基金
基于ATAC-seq策略挖掘穿心莲基因组中调控穿心莲内酯合成的增强子
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
基于单细胞ATAC-seq技术的C4光合调控分子机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于ATAC-seq技术研究交叉反应物质197调控TFEB介导的自噬抑制子宫内膜异位症侵袭的分子机制
- 批准号:82001520
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
人类胎盘合体滋养层形成分子机制及其与子痫前期发生关联的研究
- 批准号:31900602
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
单细胞RNA和ATAC测序解析肌肉干细胞激活和增殖中的异质性研究
- 批准号:31900570
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Analysis of epigenetic and neuronal circuit changes in autism on the single-cell level
单细胞水平分析自闭症的表观遗传和神经元回路变化
- 批准号:
10611017 - 财政年份:2022
- 资助金额:
$ 24.75万 - 项目类别:
Role of Epigenetically Active Environmental Compounds in Neurodevelopmental Disorders
表观遗传活性环境化合物在神经发育障碍中的作用
- 批准号:
10219009 - 财政年份:2021
- 资助金额:
$ 24.75万 - 项目类别:
The Impact of hiPSC-Derived Microglia in Human Brain Development in Health and Disease
hiPSC 衍生的小胶质细胞对健康和疾病中人脑发育的影响
- 批准号:
10661578 - 财政年份:2021
- 资助金额:
$ 24.75万 - 项目类别:
Role of Epigenetically Active Environmental Compounds in Neurodevelopmental Disorders
表观遗传活性环境化合物在神经发育障碍中的作用
- 批准号:
10395566 - 财政年份:2021
- 资助金额:
$ 24.75万 - 项目类别: